New combo before surgery aims to boost stomach cancer outcomes
NCT ID NCT07059299
First seen Jan 11, 2026 · Last updated May 09, 2026 · Updated 16 times
Summary
This early-phase trial tests a new combination of the immunotherapy drug tislelizumab plus chemotherapy (FLOT) given before surgery for people with stomach, esophageal, or junction cancer that can be removed. The goal is to see if the combination is safe and works well enough to study further. About 18 adults with locally advanced but resectable cancer will receive up to 8 cycles of the combo before surgery, instead of the standard 4 before and 4 after.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hämatologisch-Onkologische Praxis Eppendorf (hope)
NOT_YET_RECRUITINGHamburg, 20249, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Klinikum rechts der Isar München der TU München
RECRUITINGMünchen, 81675, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Krankenhaus Nordwest GmbH Institut für Klinisch-Onkologische Forschung (IKF)
RECRUITINGFrankfurt, 60488, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Leipzig
NOT_YET_RECRUITINGLeipzig, 04103, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.